期刊文献+

基于SELDI-TOF-MS技术的奶牛乳热血浆蛋白质组学分析 被引量:1

Plasma Proteomics Analysis of Dairy Cows with Milk Fever Using SELDI-TOF-MS
下载PDF
导出
摘要 奶牛乳热是围产期奶牛营养代谢性疾病,对于奶牛乳热在病理方面少有血浆蛋白质组学的研究。本研究目的是探究奶牛乳热在蛋白质组学层面的变化。试验21头患有奶牛乳热的奶牛和59头健康奶牛作为试验动物。试验通过SELDI-TOF-MS技术检验得到24个差异肽段的峰值,其中10个肽段经过Swissport Protein数据库搜索鉴定为10种差异蛋白。结果相对于对照组,乳热组中表达上调的蛋白4个;表达下调的蛋白2个;还有既表达上调又表达下调的蛋白4个。结论本次试验应用SELDI-TOF-MS技术鉴定了几个在奶牛发生乳热时表达的差异蛋白质。这些发现也为以后揭示奶牛乳热代谢性改变提供了依据。 Milk fever is an important metabolic disorder of dairy cows at calving. There have been many studies on the patho-physiology of milk fever,but the plasma proteomics of milk fever has not been reported.The aim of this study was to investigate nov-el changes in the plasma proteomics of cows with milk fever. Plasma samples were obtained from 21 Holstein cows with milk fever(T),and 59 control Holstein cows without milk fever(C).24 differential peptide peaks in the plasma of T and C cows were isolat-ed by SELDI-TOF-MS. 10 of these peaks were identified by Swissport Protein Database. The petide peaks represented 10 uniqueproteins, and had significant alterations in peaks as determined. The up-regulated proteins were 4,and the down-regulated pro-teins were 2. The other proteins which were up- regulated as well as down- regulated were 4. In conclusion,we were able touse SELDI-TOF-MS to identify several novel plasma proteins in cows with milk fever. These findings may reveal new metaboli-techanges in cows with milk fever.
出处 《中国兽医杂志》 CAS 北大核心 2016年第4期16-18,I0003,共4页 Chinese Journal of Veterinary Medicine
基金 国家自然科学基金项目主任基金(30840060) 国家自然科学基金面上项目(30972235) 黑龙江省自然科学基金面上项目(C200916)
关键词 SELDI-TOF-MS技术 蛋白质组学 乳热 奶牛 SELDI-TOF-MS plasma proteomics milk fever dairy cows
  • 相关文献

参考文献9

  • 1Peter J.De Garis,Ian J.Lean.Milk fever in dairy cows:a review of pathophysiology and control principles[J].The Veterinary Journal,2008,176(1):58-69.
  • 2Roland Lehmann,Christian Melle,Niko Escher,et al.Detection and identification of protein interactions of S100 proteins by Protein Chip technology[J].Journal of Proteome Research,2005,4(5):1717-1721.
  • 3Daniel W.Coyne.Hepcidin:clinical utility as a diagnostic tool and therapeutic target[J].Kidney International,2011,80(3):240-244.
  • 4J Jackson,R B Sim,K Whaley,et al.Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedma[J].J Clin Incest,1989,83(2):698-707.
  • 5Gary O’Donovan,Edward Kearney,Roy Sherwood,et al.Fatness,fitness,and cardiometabolic risk factors in middle-aged white men[J].Metabolism-Clinical and Experimental,2012,61(2):213-220.
  • 6Maureen S,Riedl,Patrick D.Braun,et al.Proteomic analysis uncovers novel actions of the neurosecretory protein VGF in nociceptive processing[J].J Neurosci,2009,29(42):13377-13388.
  • 7Stephen R J Salton.Gian-Luca Ferri,Seung Hahm,et al.VGF:A novel role for this neuronal and neuroendocrine polypeptide in the regulation of energy balance[J].Frontiers in Neuroendocrinology,2000,21(3):199-219.
  • 8Salazar A,PintóX,Mana J,et al.Serum amyloid A and highdensity lipoprotein cholesterol:serum markers of inflammation in sarcoidosis and other systemic disorders[J].European Journal of Clinical Investigation,2001,31(12):1070-1077.
  • 9Nevio Taglieri,Wolfgang Koenig,and Juan Carlos Kaski.Cystatin C and cardiovascular risk[J].Clinical Chemistry,2009,55(11):1932-1943.

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部